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ABSTRACT 
Blood Pressure and Red Blood Cell Magnesium, Potassium, and Calcium 
Responses to Dietary Fats, (August 1993) 
Noreen Elaine Wehrman, B. S. , Pennsylvania State University 
Chair of Advisory Committee: Dr. Karen S. Kubena 
Hypertension and cardiovascular disease are leading causes of 
death in the United States. Many nutritional factors, including 
minerals and dietary fats, have been implicated in the etiology of 
hypertension. The role of dietary fats in blood pressure regulation 
is being studied more closely, with careful consideration to their 
actions on prostaglandin synthesis, membrane fluidity and 
permeability, and electrolyte balance. This study examined the 
changes in blood pressure and red blood cell magnesium, calcium, and 
potassium concentrations in response to diets enriched in six 
different test fats in normotensive men. This study also examined 
the relationship between dietary calcium, magnesium, and potassium, 
and erythrocyte mineral concentrations and blood pressure. 
No significant reduction in either systolic or diastolic blood 
pressure was observed in subjects after following any of the diets. 
There was no significant change in red blood cell mineral 
concentrations in response to dietary treatment. 
Erythrocyte calcium, potassium, and magnesium concentrations 
were found to be significantly correlated with each other. However, 
no relationship was apparent between red blood cell mineral 
concentrations and blood pressure. In addition, no evidence of a 
relationship between dietary minerals and red blood cell minerals was 
observed. 
These results suggest that the fatty acid composition of 
the diet and mineral intake do not have a significant impact on blood 
pressure and erythrocyte mineral concentrations. 
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INTRODUCTION 
Hypertension and cardiovascular disease (CVD) are two leading 
causes of death in the United States today. Cardiovascular disease 
alone accounted for nearly one million deaths and hypertension for 
over 20, 000 deaths in 1987 (I). Hypertension is known to accelerate 
and increase the severity of atherosclerosis and CVD (2-7). Control 
of blood pressure has been shown to have a beneficial effect upon 
cardiovascular morbidity and mortality (8-11). 
Many nutritional factors have been associated with 
hypertension, and researchers have focused chiefly on the role of 
sodium, potassium, calcium, and magnesium, (12-18). More recently, 
however, the role of dietary fats in blood pressure control has been 
studied. Many researchers believe that certain dietary fats may 
control blood pressure or play a part in blood pressure regulation 
through their actions on prostaglandin (PG) synthesis, membrane 
fluidity and permeability, cell membrane transport function, and 
electrolyte balance (19-34). There is very little evidence in the 
literature today, however, about the way in which blood pressure and 
tissue mineral levels respond to specific dietary fats. 
This thesis is written in the style of the American Journal of 
Clinical Nutrition 
LITERATURE REVIEW 
PROBLEN IDENTIFICATION 
Hypertension and atherosclerosis are the two diseases in the 
United States that account for nearly 50/ of all deaths (I). 
Hypertension (HTN) is known to play an important role in the 
development of CVD. Hypertension is one of the major risk factors 
for coronary heart disease (CHD) and may lead to myocardial i schemia, 
left ventricular hypertrophy and failure due to a greater load on the 
heart, hypertensive vascular disease of the coronary arteries, 
acceleration of atherosclerosis extending to the small branches of 
the coronary arteries, cerebral atherosclerosis and cerebral 
ischemia. Hypertension both predisposes to heart attack and is more 
likely to cause heart attacks to be fatal once they do occur. 
According to Gubner, left ventricular hypertrophy is the "key lesion" 
in HTN, and it greatly increases the tendency toward ventricular 
arrhythmias and sudden death (35). 
Atherosclerosis has been shown to be accelerated by HTN with an 
increased extent of fatty streaks in the aorta and coronary arteries, 
a greater extent of raised atherosclerotic lesions, more frequent 
fibrous plaques, complicated lesions, and calcified lesions, and 
higher prevalence of stenosis in the coronary arteries (2). Koletsky 
and coworkers demonstrated a more rapid and severe development of 
atherosclerosis in the intra-abdominal arteries, leading to 
thrombosis and aneurysm (3). Hypertension in experimental monkeys 
and rabbits has led to more severe aortic and coronary lesions when 
coupled with an atherogenic diet (4-6). In addition, Bronte-Stewart 
and Heptinstall showed that only small rises in pressure were 
necessary to increase atheroma, even when not sustained (5). 
Hypertension increased the severity of aortic atherosclerosis in dogs 
as well (7). According to Dzau, HTN may cause "shear-related injury" 
to blood vessels, and injury to the endothelium and vascular cell 
proliferation amplify the development of atherosclerosis (36). 
Some believe that the danger of HTN on the cardiovascular 
system is derived mainly from the diastolic blood pressure. However, 
researchers have found that both systolic and diastolic blood 
pressures were statistically significant indices of risk of CHD, and 
either a high systolic or diastolic pressure is a good predictor of 
the risk of CHD (37-38). 
Many nutritional factors have been implicated in the etiology 
of HTN (12-18). Specifically, much of the attention is focused on 
dietary sodium, calcium, potassium, magnesium, and fats. 
There is evidence that control of blood pressure may have a 
beneficial effect upon cardiovascular morbidity and mortality. 
Control of blood pressure has been associated with a decrease in the 
incidence of stroke, fatal heart attacks, cardiovascular deaths, 
fatal myocardial infarctions, cerebrovascular events, and total 
cardiovascular mortality (8-11). Subjects who had recently stopped 
using beta-blockers for treatment of HTN had a transient four-fold 
increase in relative risk of CHD (39). 
ELECTROLYTES 
Considerable attention has been given to the role of 
electrolyte imbalances in the etiology and pathogenesis of disease, 
particularly CVD. Several epidemiological studies demonstrated a 
decrease in the incidence of CHD, CVD, and death from ischemic heart 
disease (IHD) in areas where water and soil are rich in minerals (40- 
41). 
There is accumulating evidence from both animal and human 
studies which indicates that disturbances of electrolytes may induce 
arrhythmias, high blood pressure, CVD and CHD, and even cardiac 
lesions. Numerous clinical abnormalities in both animals and humans 
have been associated with imbalances of magnesium, potassium, and 
calcium, including ventricular tachycardia, fibrillation, 
arrhythmias, premature ventricular beats, acute myocardial infarction 
(AMI), extrasystoles, congestive heart failure, cardiac lesions, 
necrosis, and HTN. Electrolyte disturbances are believed to play a 
role in arrhythmias, blood pressure, and vascular smooth muscle 
control (42-44). Lower bioavailability of minerals or abnormal 
mineral metabolism have also been recently implicated in the etiology 
of HTN (45). 
Erythrocytes were chosen as the experimental system to study 
electrolytes because of their ease in collection and availability, 
Although erythrocytes may not be the ideal system because they may 
not accurately reflect mineral status at the time of analysis or 
total body stores (46-47), they should be an adequate system for the 
study of changes in cations over time. 
Magnesium 
Magnesium deficiency has been shown to produce coronary 
arterial spasm in dogs (48). Experimental magnesium deficiency in 
rats resulted in gross morphological lesions of the myocardium, large 
areas of necrosis, calcification extending through the entire 
ventricular wall, congestion of the subepicardial vessels, and marked 
dilation of the cardiac chambers. In addition, many of the lesions 
found in the rats were characterized by proliferation of fibroblasts 
and deposition of collagen (49-50). , In spontaneously hypertensive 
rats, magnesium deficiency caused widespread tissue calcification and 
aggravated high blood pressure (51). In other rat studies, magnesium 
deficiency produced marked hyperlipidemia (52). 
In humans, hypomagnesemia has been found to be common among 
patients entering intensive care units (53-54). Serum and 
erythrocyte magnesium levels have been negatively correlated with the 
size of myocardial infarction (NI) (55). Decreased cellular 
magnesium, even in the presence of normal serum magnesium, has been 
found to predispose or contribute to digitalis-toxic arrhythmias (56- 
57). The incidence of serious ventricular ectopic beats, tachycardia 
and fibrillation was significantly higher upon admission among 
hypomagnesemic patients with AMI, and the incidence of atrial 
fibrillation and supraventricular tachycardia was also higher among 
hypomagnesemic patients (58). Exchangable magnesium was found to be 
significantly lower in patients with CHD than in a group with normal 
coronary arteries (59). Experimental human magnesium deficiency has 
produced changes in electrocardiograms, including broadening and 
decreased amplitude of the T waves, and slight prolongation of the DT 
interval, which reflects the duration of ventricular fibrillation 
(60). Iseri and coworkers described two cases of ventricular 
arrhythmias associated with magnesium depletion (61). 
Studies even have shown that persons with "Type A" behavior 
are more likely to experience an acute loss of intracellular 
magnesium than their calmer counterparts when stressed which, at 
least in part, may ultimately lead to the increase in development of 
CVD associated with "Type A" behavior (62). 
It has been suggested that magnesium deficiency decreases Na+- 
K+-ATPase pump activity, leading to an increase in intracellular 
sodium. This, in turn, causes a change in membrane potential which 
may contribute to the arrhythmias so commonly associated with 
magnesium deficiency (63). 
Magnesium is believed to have anti-ischemic properties. 
According to Shattock and coworkers, magnesium may limit cellular 
calcium overload under conditions where efflux of calcium via sodium- 
calcium exchange is reduced (64). ( Increased cellular calcium has 
been implicated in the etiology of HTN. ) Epidemiological studies 
have indicated that low intake of dietary magnesium appears to be 
related to an increased incidence of IHD (65). Patients with IHD 
retained more magnesium than controls when presented with an 
intravenous magnesium infusion, suggesting that patients with IHD may 
be magnesium deficient (66). 
Magnesium has been shown to have therapeutic value in some 
cases. Magnesium therapy has been reported to completely and 
immediately abolish arrhythmias and restore normal sinus rhythm (61). 
Magnesium sulfate has been proven to be an effective therapy for 
Torsades de Pointes and for toxic arrhythmias associated with 
hypomagnesemia (61, 67). After intravenous bolus injections of 
magnesium sulfate, patients with resistant ventricular fibrillation 
have been defi bri llated (68), Multifocal atrial tachycardia 
associated with hypomagnesemia and hypokalemia in the absence of 
other predisposing factors has been resolved after normalization of 
both serum potassium and magnesium (69). Magnesium infusion has led 
to an increase in cellular potassium and a decrease in the frequency 
of ventricular ectopic beats (70), Magnesium replacement has 
restored normal intracellular levels of both potassium and magnesium 
(71). Magnesium may even help protect against the blood pressure 
response to stress and high salt intake (72). 
There is conflicting evidence in the literature about the role 
of dietary magnesium on blood pressure. Although, as previously 
mentioned, epidemiological studies point to the fact that dietary 
magnesium appears to play a role in HTN, supplementing the diet with 
magnesium oxide was found to have no significant effect on systolic 
blood pressure among spontaneously hypertensive rats fed low, normal, 
and high magnesium diets (73). In another study however, 
spontaneously hypertensive rats fed a magnesium-free diet for two 
months had a greater mean arterial pressure, total peripheral 
resistance, and renal vascular resistance (51). 
Serum and erythrocyte magnesium has been related to blood 
pressure as well. Serum magnesium has been inversely correlated with 
systolic blood pressure and mean blood pressure (74). On the other 
hand, plasma and erythrocyte magnesium did not differ significantly 
between normal pregnant and pregnancy-induced hypertensives (75). 
The Role of Nagnesium in Ion Transport 
Nagnesium appears to have an important role in ion transport in 
red blood cells (76). Intracellular magnesium influences the 
activities of several membrane transport systems, including the 
sodium pump which exchanges three sodium ions for two potassium ions, 
the Na+-K+-Cl cotransport system which moves these three ions across 
the cell membrane, and the K+-Cl cotransport system which moves one 
potassium ion with one chloride ion across the cell membrane. 
Intracellular ionized magnesium itself can be altered by the rate of 
magnesium transport across the cell membrane. 
Alterations in magnesium status have been associated with 
subsequent alterations in the status of calcium and potassium. 
Hypokalemia and hypocalcemia occurred in the majority of patients 
with experimental hypomagnesemia (60). In the magnesium-deficient 
rat, lymphocyte potassium was decreased while lymphocyte calcium was 
increased (77). 
The Relationship Between Nagnesium and Potassium 
Cellular concentrations of magnesium and potassium are very 
closely associated with each other. A highly significant correlation 
has been found between potassium and magnesium concentrations within 
the lymphocytes and erythrocytes from normotensive subjects (78). A 
significant correlation has also been found between muscle magnesium 
and potassium content in muscles with normal calcium (79). 
Because magnesium is a necessary coenzyme for ATPases, one of 
which supplies the energy to transport sodium out of the cell and 
potassium into the cell, a deficiency of magnesium may lead to an 
inability of the cell to accumulate potassium. The resting membrane 
potential is largely dependent on the ratio of intracellular and 
extracellular potassium. A decrease in the intracellular potassium 
concentration causes the cell to be more easily excited, and this has 
been implicated in the etiology of high blood pressure. Chronic 
potassium depletion, on the other hand, lowers vascular resistance 
and blood pressure (80), although increasing dietary intake of 
potassium alone in normotensives has been shown to have no effect on 
blood pressure (81). 
To demonstrate the relationship between magnesium and 
potassium, several studies presented evidence that potassium 
deficiency cannot be corrected without the subsequent infusion of 
magnesium. One study showed that the cellular potassium content of 
subjects on long-term diuretic treatment, who were suffering from 
congestive heart failure and were being treated for arterial HTN, and 
who presented with symptoms of ventricular ectopic beats, did not 
respond to potassium infusion alone. Rather, magnesium infusion led 
to an increase in cellular potassium and a decrease in the frequency 
of ventricular ectopic beats (70). 
Ventricular fibrillation has been related to low serum 
potassium levels in patients in coronary care units (82). Cumulative 
potassium deficit, myocardial tissue potassium, and plasma potassium 
levels have been correlated to the likelihood of spontaneous 
ventricular fibrillation during AMI (83). 
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The Relationship Between Magnesium and Calcium 
A deficiency of magnesium seems to have a similar effect on the 
balance between intracellular and extracellular calcium. The resting 
membrane is only slightly permeable to calcium. Cellular calcium 
balance is maintained by the activities of pumps in addition to 
voltage-dependent and receptor-operated channels (84). Indirectly, 
the calcium balance of the cell is partially maintained by the 
magnesium-dependent Na+-K+-ATPase pump because the inwardly moving 
sodium is used by the Na+-Ca +-ATPase pump to extrude calcium from 
the cell. Hannaert and coworkers have shown that an increased sodium 
content in vascular smooth muscle cells decreases net calcium 
extrusion through sodium and calcium exchange, thus increasing 
cytosolic free calcium (85). 
Decreases in intracellular magnesium reduce the activity of the 
magnesium-dependent Ca +-ATPase pump, which normally pumps calcium to 
the outside of the cell and incorporates calcium into the endoplasmic 
reticulum by activity on the endoplasmic reticular membrane. 
Normally, calcium is sequestered in the endoplasmic reticulum, which 
helps maintain cytosolic calcium balance. However, with a decreased 
Ca +-ATPase activity, cytosolic calcium is increased. In addition, 
with magnesium deficiency, there is an increased interchange across 
the mitochondrial membrane between sodium and calcium, which produces 
an even greater increase in cytosolic calcium. Thus, an impairment 
of the pump systems or the ionic gradient may cause an increase in 
cytosolic calcium. An impaired intracellular calcium content has 
been confirmed in patients suffering from essential HTN (86) . 
The Relationship Between Calcium and Blood Pressure 
An increased intracellular level of calcium has been related to 
HTN. Nhen the concentration of intracellular calcium reaches a 
certain threshold, calcium binds to the protein calmodulin, which 
initiates a series of biochemical events that eventually result in 
actin-myosin interaction and smooth muscle contraction. This 
reaction is dependent upon the concentration of calcium available in 
the cytosol (87). If the concentration of cytosolic calcium reaches 
an abnormally high level, the calcium will enter the mitochondria, 
the major storage site of intracellular calcium. The efflux pathway 
will become saturated and the net accumulation of calcium will exceed 
mitochondrial capacity, eventually causing cell dysfunction and cell 
death (84). Magnesium, in this respect, actually may act as a 
calcium-blocking agent. In addition, experimentally increasing 
intracellular calcium caused a decrease in intracellular potassium 
and an increase in sodium (88). 
Calcium overload and HTN may play a vital role in the 
development of ANI. Cellular calcium overload is known to be highly 
pathogenic, and leads to necrotization and calcinosis of the arterial 
media in rats. High intracellular calcium enhances the contractile 
response to vasoconstrictive stimulus in systemic HTN, leading to 
much more severe coronary spasm than in normotensives, possibly 
ending in AMI. In addition, Gasser noted that calcium overload has 
been shown to be the basic physiologic principle in the development 
of myocardial cell necrosis (89), 
Calcium supplementation has been shown to decrease blood 
12 
pressure in rats (90-92) and humans (93-95). Weanling spontaneously 
hypertensive rats placed on a low calcium diet developed higher blood 
pressure than those on an intermediate or high calcium diet (96). 
A low plasma ionized calcium concentration is inversely related 
to blood pressure (97-98). An epidemiological study found a positive 
relationship between serum calcium and blood pressure (99). Hvarfner 
and coworkers found an impaired renal tubular reabsorption of calcium 
among essential hypertensives, resulting in a decreased level of 
plasma ionized calcium (97). 
POLYUNSATURATED FATS 
Dietary fats may be related to blood pressure (100), An 
increase in the intake of polyunsaturated fats in the diet has been 
associated with a subsequent decrease in blood pressure. Both 
normotensive and hypertensive subjects significantly decreased their 
blood pressures when fed a diet low in total fat (25%%d) with high P:S 
ratio (I:0), and high in vegetables. The decrease was greater among 
the hypertensives, especially for diastolic pressure (101). In 
another study in which the subjects were fed a vegetarian diet, both 
systolic and diastolic blood pressures fell during the vegetarian 
diet and rose to the level observed before the vegetarian diet after 
resumption of an omnivorous diet. The P:S ratio increased from 0. 4 
during the omnivorous diet to 0. 8 during the vegetarian diet (102). 
The dietary changes in these two studies, however, were not confined 
to a single nutrient, so it is difficult to exclude the effects that 
other nutrients may have on blood pressure. 
Beilin and coworkers reviewed studies of vegetarians and the 
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effect of vegetarian diets on blood pressure. The authors agreed 
that there is strong evidence for an antihypertensive effect of a 
vegetarian diet, independent of sodium intake and other lifestyle 
changes (103). In addition, Margetts and coworkers concluded that 
the effect on blood pressure of a vegetarian diet cannot be 
contributed solely to the effect of a change in P:S ratio or dietary 
fiber. Rather, a combination of these two factors, or perhaps 
another aspect of diet may be responsible (104). 
Even small changes in the amount of polyunsaturated fats in the 
diet may cause a significant decrease in blood pressure. Comberg and 
coworkers demonstrated that a significant decrease in diastolic blood 
pressure and a small, although non-significant, decrease in systolic 
blood pressure followed an increase in polyunsaturated fatty acids 
(PUFAs) from only 2X to 4X of total calories (19). 
Hetzel and coworkers reviewed epidemiological studies which 
indicated that the fall in CHD mortality in the USA and Australia 
since 1967, characterized by a fall in sudden deaths, was associated 
with an increase in polyunsaturated fat consumption since 1960. 
These researchers supported these studies with their own laboratory 
experiments which also indicated a protective effect of 
polyunsaturated fats against sudden cardiac death ( 105). 
Supplementing the diet with safflower seed oil (containing 72% 
linoleic oil) has also caused a decrease in blood pressure (20). 
Treating subjects with both groundnut oil (20-28% PUFA) and safflower 
oil (70-75%%d PUFA) resulted in a significant decrease in diastolic 
blood pressure, and significant decreases in both systolic and 
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diastolic blood pressures occurred in subjects treated with these 
oils in addition to traditional antihypertensive medication (106). 
Additionally, rat studies have shown that feeding sunflower oil 
lowers systolic blood pressure, and when chain length is similar, the 
degree of unsaturation is a vital factor in controlling blood 
pressure (21). 
Little has been tested about the effect of specific dietary 
fats on blood pressure. Some researchers claim that it is the 
particular fatty acid profile rather than the P:S ratio which affects 
blood pressure. In a recent study by Karanja and coworkers, fish oil 
consumption (36N kcals as fat, P:S = 0. 84) resulted in lower blood 
pressure compared to butterfat (P:S - 0. 07) and corn oil (P:S - 4. 54) 
in spontaneously hypertensive rats (107). In another study, 
polyunsaturated fatty acids had a more positive effect on the 
utilization of calcium than monounsaturated fatty acids. Poor 
bioavailablity of calcium occurred when feeding a diet high in canola 
oil, and the bioavailability of magnesium was improved by the 
addition of fish oil to soybean oil in the diet (22). 
PROSTAGLANDINS 
The supposed effect that changing the P:S ratio has on blood 
pressure has been attributed, at least in part, to the influence of 
increased linoleic acid on prostaglandin (PG) synthesis. Linoleic 
acid (18:2), the most abundant polyunsaturated fatty acid in the 
diet, can be desaturated and elongated to form arachidonic acid 
(20:4), which is the precursor of prostanoids of the diene series. 
Prostaglandins, 20-carbon unsaturated fatty acids, are formed from 
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arachidonic acid by oxygenation and cyclization (108). Certain PGs 
are known to exert a lowering effect on blood pressure. 
Researchers believe that physiological levels of PGs may serve 
to regulate blood pressure through renal diuretic and saliuretic 
effects and renal vasodilation (109). In fact, Comberg and coworkers 
had speculated that renin and aldosterone activity may also be 
involved in the effect that polyunsaturated fats, the PG precursors, 
have on blood pressure (19). 
Berl and coworkers suggested a direct or indirect role for 
renal PGs in the action of vasopressin (110). Altsheier and 
coworkers suggested that PGs play a role in natriuresis (111). In 
addition, Lee and coworkers demonstrated that intravenous PG infusion 
in hypertensive patients induced normotension associated with normal 
renal blood flow and normal sodium excretion (112). Stokes proposed 
that PGs enhance water excretion by affecting three main 
physiological functions. These include reducing vasopressin- 
dependent osmotic water permeability of the collecting tubules, 
enhancing medullary blood flow, and inhibiting NaCI absorption. In 
this regard, renal PGs antagonize the action of vasopressin (a 
hormone which has antidiuretic effects and elevates blood pressure) 
(113). 
There is accumulating evidence that PG production can be 
modified through diet. Grataroli and coworkers suggested that the 
decrease in gastric PGE2 demonstrated in rats fed fish oil may be the 
result of substitution of arachidonic acid by n-3 fatty acids or by 
activation of PGE2 catabolism (23). Watanabe and coworkers found 
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that dietary fats significantly altered fatty acid composition of the 
brain, adrenal gland, renal medulla, and cortex phospholipids in 
spontaneously hypertensive rats, although they did not affect blood 
pressure ( 114). 
The precursors of PGs, linoleic and arachidonic acids, are 
released from plasma membrane phospholipids by the action of 
phospholipase A2. Because the composition of the plasma membrane is 
constantly changing and is affected by diet, it may be possible that 
increasing the amount of unsaturated fatty acids in the diet, thus 
increasing the concentration of linoleic and arachidonic acids in the 
plasma membrane, will have an effect on substrate concentration for 
PG synthesis. 
Significant changes in plasma fatty acids and the composition 
of phospholipids have been brought about by dietary fat supplements 
between five and 40% of dietary calories (24). Supplementing the 
diet with linoleic acid has been shown to elevate peripheral 
leukocyte membrane linoleic acid significantly (20). Epstein and 
coworkers demonstrated that the infusion of Liposyn (a fat emulsion 
derived from safflower oil) increased the rate of excretion of PGs, 
supporting the fact that providing linoleic acid can increase PG 
synthesis in man (25). 
An increase in linoleic acid in the diet has been shown to 
stimulate PGE biosynthesis in man, leading 'to effects in systems 
which control renal function and sodium and potassium balance (26), 
Supplementing the diet with linoleic acid increased gastric PGE and 
PGE2 production in humans (27). Mahoney and coworkers, on the other 
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hand, showed that linoleic acid supplementation (40%%u energy as 
sunflower seed oil) did not protect against experimentally-induced 
renal HTN, in spite of a small increase in renal linoleic acid 
content and an increase in PG systhesis (28). 
Tobian and coworkers demonstrated that Dahl rats, which were 
genetically susceptible to salt HTN, had much lower PGE2 levels in 
renal papillary tissue than a similar strain which was resistant to 
salt HTN. A high linoleic diet increased the concentration of PGE2 
in the renal papillae of both susceptible and resistant rats. The 
susceptible rats had a decreased capacity for natriuresis, and the 
low papillary PGE2 was believed to contribute to their intrinsic 
inability to excrete sodium rapidly. A high linoleic diet eliminated 
part of the large rise in blood pressure brought on in the 
susceptible rats by a diet high in NaC1, delayed the start of the 
blood pressure rise and prevented it from ever reaching the level 
that would have been reached on a diet lower in linoleic acid (29). 
Dietary linoleic deprivation significantly increased systolic 
blood pressure while suppressing vascular PGI2, a vasodilator PG 
(30). In rats fed a diet deficient in linoleic acid, blood pressure 
rose significantly when fed a high salt diet, and less sodium, 
potassium, and chloride were excreted. In addition, renal 
cyclooxygenase metabolism was significantly depressed in linoleic 
acid deprived rats (31). 
Watanabe and coworkers (II4) demonstrated that spontaneously 
hypertensive rats fed differing levels of n-6 and n-3 fatty acids had 
relatively higher levels of the 2-series PG precursor (20:4 n-6) and 
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a relatively low level of 1- and 3-series PG precursors (20:3 n-6 and 
20:5 n-3). The 2-series PGs act both as vasodilators and as 
vasoconstrictors, and the 1- and 3-series PGs act as vasodilators. 
The researchers proposed that unbalanced PG precursor levels may be 
partially responsible for the development of HTN in spontaneously 
hypertensive rats (114). 
There was a three-fold decrease in plasma and dermal 
PGE2 levels in mice fed menhadin oil (rich in n-3 fatty acids) versus 
corn oil (rich in n-6 fatty acids). The difference may be attributed 
to metabolic competition for cyclooxygenase activity (32). 
Houwelingen and coworkers, in a review of studies on the effect 
of dietary fat on PGE production, stated that the type of dietary fat 
is important in stimulating prostanoid production in vitro (33). 
Dietary oils did not cause significant differences in renal 
PGE2 production in vivo. They did, however, modulate the fatty acid 
composition and phospholipid composition of renal medulla, believed 
to be the major site of renal PGE2 production, in vivo (33). 
Margetts and coworkers showed that omnivorous normotensive 
subjects significantly increased the relative concentrations of 
linoleic acid in plasma phospholipids when on a high P:S ratio diet, 
even though this produced no consistent effect on mean blood 
pressure (115). Sachs and coworkers found that although linoleic and 
oleic acids were enriched significantly in the plasma cholesteryl 
esters, phospholipids and triglycerides of normotensive persons 
supplemented with dietary linoleic or oleic acids, there was no 
increase in arachidonic acid in any of these fractions (34). 
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However, it has been previously shown that the phospholipid and fatty 
acid composition of human red blood cells changes very little, even 
with extreme variations in dietary fat (116). 
LIPID BILAYER NENBRANE 
Another proposed way in which an increase in polyunsaturated 
fats in the diet may decrease blood pressure is through an increase 
in the fluidity and permeability of cell membranes. The cell is 
surrounded by a lipid bilayer membrane which is selectively permeable 
to certain ions, including magnesium, potassium, calcium, and sodium. 
The ionic gradient of the cell in its environment is maintained by 
the cell membrane through several processes, including the energy- 
requiring, magnesium-dependent Na+-K+-ATPase pump. When these 
processes are impaired, the ionic gradient is impaired as well, and 
certain electrolyte imbalances may occur. Cooper has reviewed the 
role of cell membrane fluidity abnormalities in the pathogenesis of 
disease (117). 
Gobel and coworkers demonstrated that cation transport systems 
which were modified in alcoholics were associated with increased 
blood pressure (118), Na+-Li countertransport has been shown to be 
higher among hypertensives than normotensives (llg), Na+-K+-Cl 
cotransport in the vascular smooth muscle cells, the putative target 
tissue for essential HTN of spontaneously hypertensive rats, was 
found to be significantly lower than that of normotensive rats (120). 
On the other hand, pregnant women who developed pre-eclampsia 
(pregnancy associated HTN) showed no difference in sodium-potassium 
cotransport in erythrocytes, compared to normotensive pregnant women 
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(121). 
The dry weight of the red blood cell membrane contains 
approximately 48% protein and 44/ lipid (122). The process of 
maintaining cellular electrolyte balance has been shown to be related 
to the composition of the lipid fraction of the cell membrane. 
The composition of the cell membrane is not fixed, and changes 
in its composition occur readily. Red blood cells have a deficiency 
of acetyl CoA carboxylase, an enzyme needed for de novo synthesis of 
fatty acids. Therefore, these cells are incapable of synthesizing 
fatty acids on their own (123). The cells, however, are involved in 
mechanisms for turnover of lipids and lipid renewal ( 124). 
Plasma unesterified fatty acids have been shown to interact 
strongly with human erythrocytes. Unesterified fatty acids in plasma 
are transferred from serum albumin to receptor binding sites on cell 
surfaces ( 125). The fatty acids are transferred initially to a 
"superficial" red cell pool, subsequently transferred to a "deeper" 
pool in the membrane, then incorporated into membrane phospholipids 
(126). In addition, the major mechanisms of lipid renewal are 
passive exchange with preformed serum phosphatides, and active 
assembly of phosphatides from lysophosphatides and free fatty acids 
(127). 
Of the four major erythrocyte phospholipids, 
phosphatidylserine, phosphatidyethanolamine, phosphatidylcholine, and 
sphingomyelin, only the latter two have been known to be actively 
exchangable with plasma. Reed concluded from his research that 
". 
. . alterations in the fatty acid composition of the plasma compounds 
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can affect, in a very significant manner, the corresponding 
erythrocyte membrane lipids during the life span of a given red blood 
cell" (128). It is because of this exchange between plasma lipids 
and those in red blood cell membranes that the phospholipids and 
fatty acids in red blood cells tend to resemble those in plasma 
(117). 
Plasma fatty acids can be altered through diet. Results from 
one study demonstrated that an olive oil-rich diet, containing a 
large amount of oleic acid, influenced the lipid composition of the 
cell membrane and the cation transport systems which are altered in 
essential HTN, specifically the Na+-K+-ATPase system (129). In 
another study in which the erythrocytes of normotensives and 
hypertensives were compared, the researchers found that the lipid 
composition of the erythrocytes membranes influences the Li-Na+ 
countertransport system of the cells (130). Oietary linoleic acid 
supplementation may affect the flux of ions across the cell membrane, 
thus causing changes in blood pressure (131). Plasma triglycerides 
and cholesterol have also been associated with ion transport systems 
(132). 
In one study, membrane fluidity in platelets of hypertensive 
subjects was shown to be less than that of normotensive subjects, and 
the platelet membranes of normotensive subjects were shown to contain 
a significantly greater fraction of linoleic acid than the platelet 
membranes of hypertensive subjects. In addition, erythrocytes from 
hypertensives were shown to be less deformable that those of 
normotensives. The researchers proposed that the abnormality of the 
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membrane may be global, affecting membranes of all cells (133). 
An in vitro study of mouse neuroblastoma cells showed that 
short-term supplementation of the growth medium with oleic or 
linoleic acid increased the permeability of the neuroblastoma 
membranes to Na+ while causing a subsequent decrease in the 
permeability to K+. These effects were not seen when the growth 
medium was supplemented with stearic acid (18:0). The researchers 
concluded that these changes were not caused by changes in the 
Na+-K+-ATPase-mediated K+ influx or in the K+ gradient (134). 
Another study showed that dietary linoleic and oleic acids are 
unlikely to have major effects on membrane-dependent functions of red 
blood cells related to HTN (135). 
Papahadjopoulos and coworkers stated that the fluidity of the 
fatty acyl chains of membrane phospholipids is essential for several 
transport systems, including the Na~-K+-ATPase system (136). The 
fluidity probably provides the motional freedom needed to allow 
proteins within the membranes to undergo conformational changes and 
rotational and translational movements associated with their activity 
(136). Cheng and Chen noted that membrane fluidity is significantly 
influenced by the composition of the membrane lipids, and a reduction 
in the fluidity of membranes is due to the deceleration of lipid 
movement (137). 
The cholesterol content of the plasma membrane is also believed 
to affect the permeability and fluidity of the membrane by affecting 
the degree of "tightness" of the lipid components. Kroes and Ostwald 
demonstrated a decrease in the permeability of cholesterol-loaded 
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erythrocytes to electrolytes both in vitro and in vivo ( 138), Both 
the active and the passive components of the Na+ efflux decreased in 
the cholesterol-loaded cells with a subsequent decrease in the number 
of Na+ pump sites (138). Papahadjopoulos and coworkers demonstrated 
that the presence of cholesterol partially or totally inhibited the 
activity of the phospholipid-activated Na+-K~-ATPase, depending on 
the degree of unsaturation of the phospholipid component. An 
increase in plasma cholesterol induced a decrease in membrane 
fluidity and an increase in Na+-K~-ATPase in plasma red cells (139). 
In addition, an increase in the level of cholesterol in cell 
membranes could interfere with some functions of the membrane, 
probably by controlling the fluidity of the acyl chains of the 
phospholipids, with injurious effects to cell metabolism and 
viability (136). Changes in the fluidity of membranes due to lipid 
accumulation may cause changes in the functioning of receptors or 
carriers within the membrane, thus contributing to metabolic 
disturbances (140). 
It has been shown that plasma cholesterol, which can be 
increased by an increase in dietary cholesterol and/or saturated fat, 
may modify cellular calcium since a high membrane cholesterol content 
induces a greater influx of calcium and decreases the activity of the 
calcium pumps, which may play a role in the development of arterial 
HTN (141) . 
The purpose of this study was to determine blood pressure and 
red blood cell magnesium, potassium, and calcium responses associated 
with intake of various dietary fats. 
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NATERIALS AND NETHODS 
BACKGROUND INFORNATION ON THE CLINICAL TRIAL 
Thirty male volunteers between the ages of 30 and 60 (recruited 
as subjects in an investigation sponsored by the Palm Oil Research 
Institute of Nalaysia) were subjects in this investigation. The 
volunteers qualified for the study on the basis of the information 
obtained from a complete medical examination, including an 
electrocardiogram (EKG) and an analysis of blood chemistry. The 
subjects had a blood cholesterol level between 130-220 mg/dl, a blood 
pressure of not more than 90 mm Hg diastolic and not more than 150 mm 
Hg systolic, and were within 80-120/ of their ideal body weight. The 
subjects were not on any medication except that which was approved by 
the physician working with this study. The subjects showed no 
evidence of metabolic disorders, psychiatric disorders, or 
alcoholism. The subjects were expected to provide medical and diet 
histories, to adhere to specific diet modifications, to submit to 
venipuncture following a 12-hour fast, to keep diet records, to 
maintain body weight within five pounds (2. 27 kilograms), to maintain 
pretrial exercise level and alcohol consumption, and to refrain from 
taking diet supplements (vitamins), steroid injections, or illicit 
drugs. In return, the subjects were provided with nutrition 
information, access to all data resulting from analyses pertaining to 
them, provision of food products containing the test fats, and 
financial reimbursement contingent upon completion of the study. 
The diets consisted of 40% energy as fat. Test fats were 
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incorporated into cookies, ice cream, milk, and spreads and oils and 
were consumed by the subjects as 60% of the total fat. The test fats 
include crude palm oil (CPO), refined palm oil (RPO), butter (BUT), 
sunflower oil (SUN), Parkay margarine (PAR), and a sunflower/refined 
palm oil blend (SPO). The percentages of types of fatty acids for 
each test fat were determined by the laboratory of Dr. Randall Wood, 
Texas ARM University (Table 1). The diets were designed to fit the 
usual diets of the participants through the use of exchange lists. 
The design of the study was that of a Latin Square in which all 
subjects followed all diets. 
The experiment consisted of six diet periods, each of six weeks 
duration and corresponding to one specific test fat at each time, in 
which the subjects were expected to follow a prescribed diet plan. 
Each diet period was followed by a six week "washout period" in which 
the subjects were expected to eat their normal diet. During each 
diet period, blood was drawn weekly at the same time (approximately 
8:00 a. m. ) following a 12-hour fast, by venipuncture by a registered 
medical technician. The blood was collected in Venoject AutoSep 
serum separation evacuated blood collection tubes (Terumo Medical 
Corporation, Elkton, Maryland) containing an inert barrier-forming 
material (specific gravity between serum and coagulum after clotting 
and centrifugation) and a clot activator (disk carrying silica 
particles). Body weights were also measured during the visit when 
blood was sampled. 
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TABLE I 
Percentages of types of fatty acids in test fats*+ 
SAT SAT TOTAL C I 5 TRANS TOTAL 
(&15: 0) (&15: 0) SAT MONO MONO POLY 
BUT 
PAR 
SUN 
CPO 
RPO 
SPO 
16. 0 46. 8 62. 8 25. 2 4. 0 3. 9 
0. 5 20. 4 20. 9 33. 6 26. 2 14. 6 
0. 0 12. 8 12. 8 17. 5 0. 0 65. 6 
0. 0 40. 7 40, 7 46. 0 0. 0 10, 9 
0. 0 46. 5 46. 5 40. 8 0. 0 9. 3 
0. 0 34. 1 34. 1 33. 2 0. 0 25. 3 
* BUT, butter; PAR, Parkay margarine; SUN, sunflower oil; CPO, crude 
palm oil; RPO, refined palm oil; and SPO, sunflower/palm oil 
blend; Sat, saturated fatty acids; Mono, monounsaturated fatty 
acids; Poly, polyunsaturatd fatty acids. 
+ Only major fatty acids of even chain lengths &10:0 and &20:0 have 
been included. 
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PRESENT STUDY 
Number of Subjects by Treatment Group 
One of the 30 subjects was not present for blood drawings and 
blood pressure readings for two of the weeks (weeks 3 and 6), and 
subsequently was dropped from this study. There were between three 
and seven subjects per treatment group, and the breakdown of the 29 
subjects by dietary group is listed in Table 2. 
Electrolytes and Blood Pressures 
The present study involved analysis of red blood cell calcium, 
magnesium, and potassium from the second baseline week (week 0), week 
3 and week 6 of Diet Period 4. In addition, both systolic and 
diastolic blood pressures were measured during these same weeks with 
a sphygmomanometer (W. A. Baum and Company, Incorporated, Copiague, 
N. Y. ) and stethoscope (Premier) by the author who was trained by the 
American Red Cross. The blood pressures were taken from both the 
right and left arms of the subjects while in a sitting position 
before the blood sample was drawn. Left and right blood pressures 
were combined to obtain an average systolic and average diastolic 
blood pressure for each subject. 
Dietary Data 
Three three-day food intake records were kept by the subjects 
during week 0, week 3, and week 6 of Diet Period 4, In cases where 
food intake records were missing, the food intake records available 
were used to calculate average intakes of nutrients. A nutritional 
anaylsis was performed on each of the food intake records 
(Nutrapractor 6000, Practocare, Inc. , San Diego, CA). 
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TABLE 2 
Number of subjects by dietary group and total number* 
Dietary Group 
BUT 
PAR 
SUN 
CPO 
RPO 
SPO 
Total 29 
* BUT, utter; PAR, Parkay margarine; SUN, sunflower oil; CPO, cru e 
palm oil; RPO, refined palm oil; and SPO, sunflower/palm oil 
blend; 
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SAMPLE PREPARATION 
All stainless steel instruments used for this analysis were 
soaked in a 5% EDTA solution (Appendix, J. T. Baker Incorporated, 
Phillipsburg, New Jersey) for at least one hour and rinsed with 
distilled deionized water (Milli-0 Pyrogen-free Water System, 
Millipore Corporation). All glassware was soaked in a 10%%d nitric 
acid solution (Appendix, Mallinckrodt Incorporated, Paris, Kentucky) 
for at least 24 hours, rinsed in distilled deionized water, and 
allowed to air dry. 
The blood samples were frozen and transferred on ice to the 
laboratory where they remained frozen at -10 C until time of 
analysis. The samples were then thawed at room temperature. 
Any remaining serum was removed by inversion of the tube onto a 
piece of absorbent paper. The inert gel separator was removed from 
the blood collection tube with a stainless steel spatula, using a 
scooping motion, and discarded. The coagulum was transferred to a 
beaker. The sample in the beaker was placed in a 100-140 C oven 
(Precision Scientific Group, GCA Corporation, Chicago, IL) and dried 
for a minimum of 48 hours. The samples were removed from the oven 
and transferred to a dessicator to cool. 
After the samples had cooled, the samples were broken up and an 
aliquot of approximately 0. 5 gram of the dried coagulum was weighed, 
in duplicate, using an electronic analytical balance (Series 1600, 
Sartorious Balances and Scales, Brinkmann Instruments Company, 
Division of Sybron Corporation, Cantiague, New York). The weights 
were recorded, and the samples were transferred to a beaker. The 
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samples were digested with aproximately 10 ml concentrated nitric 
acid using a remote control hot plate (Model RC2240, Series 411, 
Barnstead/Thermolyne Corporation, Dubuque, Iowa). More nitric acid 
was added as needed throughout the digestion. When the digest was 
clear (not cloudy), the nitric acid was allowed to evaporate until 
approximately 0. 5-1. 0 ml digested sample remained in the beaker. The 
digest was transferred to a 50-ml volumetric flask with a IN 
lanthanum chloride solution (Appendix, Fischer Scientific, Fair Lawn, 
New Jersey), rinsing the sides of the beaker to ensure complete 
transfer, and adjusted to volume with the lanthanum chloride 
solution. The digest was filtered to remove any silica particles, 
and the digest was transferred into culture tubes for mineral 
analysis. 
RED BLOOD CELL MINERAL ANALYSIS 
The digests were analyzed for magnesium, calcium, and potassium 
using an atomic absorption spectrophotometer (Nodel AA-6, Varian 
Techtron, Palo Alto, California), Magnesium samples were diluted 
500:I, potassium samples 397:I, and calcium was not diluted for 
anaylsis. Wavelengths used for calcium, magnesium, and potassium 
were 422. 7, 285. 2, and 766. 5 nm respectively. 
The results from the atomic absorption spectrophotometry, were 
reported in parts per million (PPM) (Appendix). 
STATISTICAL ANALYSIS 
All statistical tests were performed using the Statistical 
Analysis System (SAS). Blood pressure and red blood cell data were 
analyzed using the general linear model with repeated measures. 
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Correlation coefficients were also calculated for blood pressure and 
red blood cell data and dietary intake of minerals and 
blood pressures. 
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RESULTS 
DIETARY DATA 
Modified Foods 
Modified fats were incorporated into the diets of the subjects 
in the form of spreads, ice cream, milk, and cookies. The fatty acid 
profiles of the modified foods varied according to which test fat was 
incorporated into the foods and are listed in Tables 3-7. 
Intake of Total Fat, Nodified Fat, Magnesium, Calcium, Potassium, 
Linoleic Acid, and P:S Ratios 
All six treatment groups consumed approximately 35 to 42K of 
their total daily calories from fat, and 14 to 22% calories from 
modified fat. These percentages were not significantly different 
among treatment groups. Average percentages of calories as fat and 
percentages of calories as modified fat are listed in Table 8 by 
treatment group. Average percentages of modified fat as total fat 
are listed in Table 9 by treatment group, and averaged between 
approximately 36 and 62/. . These too were not significantly 
different. 
There were no significant differences among treatment groups in 
the amount of dietary magnesium, calcium, and potassium consumed 
during Diet Period 4. These figures are listed in Table 10 and are 
compared to their Recommended Dietary Allowances (RDAs) or Estimated 
Minimum Requirements (EMRs) and reference values found in the 
literature ( 144, 145). The SUN diet contained the largest percentage 
of calories from linoleic acid and the highest P:S ratio. Average 
percentages of calories as linoleic acid and P:S ratios differed by 
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TABLE 3 
Amounts of fatty acids per tablespoon of modified spreads and oils* 
BUT PAR SUN CPO RPO SPO 
total fatty 
acids 11. 47 11. 58 13. 81 13. 81 13. 81 13. 97 
10:0 
12:0 
14:0 
16:0 
16:1 
18:0 
18:1 
18:2 
18:3 
P:5 
0. 58 
0. 59 
1, 54 
3. 58 
0. 16 
1. 26 
2. 44 
0. 41 
0. 05 
0. 06 
0. 00 
0. 00 
0. 06 
1. 45 
0. 00 
0. 91 
6. 94 
1. 63 
0. 06 
1. 25 
0. 00 
0. 00 
0. 00 
1. 09 
0. 00 
0. 68 
2. 42 
9. 00 
0. 06 
6. 36 
0. 00 0. 00 0. 00 
0. 00 0. 00 0. 00 
0. 00 0. 00 0. 00 
5. 15 5. 80 4. 12 
0. 04 0. 03 0. 03 
0, 47 0. 62 0. 64 
6. 31 5. 61 4. 61 
1. 46 1. 23 3. 48 
0. 04 0. 06 0. 06 
0. 19 0. 19 0. 37 
* BUT, butter; PAR, Parkay margarine; SUN, sunflower oil; CPO, crude 
palm oil; RPO, refined palm oil; SPO, sunflower/palm oil blend; 
and P:S, polyunsaturated to saturated fatty acid ratio. 
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TABLE 4 
Amounts of fatty acids per cup of modified milk* 
BUT PAR SUN CPO RPO SPO 
total fatty 
acids 8. 38 8. 47 8. 11 8. 11 8. 11 8. 19 
10:0 
12:0 
14:0 
16:0 
16:1 
18:0 
18:1 
18:2 
18:3 
0. 43 
0. 44 
1. 12 
2. 61 
0. 12 
0. 92 
1. 78 
0. 30 
0. 03 
0. 00 
0. 00 
0. 04 
1. 06 
0. 00 
0. 67 
5. 07 
1. 19 
0. 04 
0. 00 
0. 00 
0. 00 
2. 42 
0. 00 
0, 40 
1. 42 
5. 29 
0. 03 
0. 00 0. 00 0. 00 
0. 00 0. 00 0. 00 
0. 00 0. 00 0. 00 
3. 03 3. 41 2. 42 
0. 02 0. 02 0. 02 
0. 28 0. 36 0. 38 
3. 71 3. 29 2. 70 
0. 86 0. 72 2. 04 
0. 02 0. 03 0. 03 
* BUT, butter; PAR, Parkay margarine; SUN, sunflower oil; CPO, crude 
palm oil; RPO, refined palm oil; and SPO, sunflower/palm oil blend. 
TABLE 5 
Amounts of fatty acids per cup of modified ice cream* 
BUT PAR SUN CPO RPO SPO 
total fatty 
acids 19. 47 19. 66 18. 78 18. 78 18. 78 19. 00 
10:0 
12:0 
14:0 
16:0 
16:1 
18:0 
18:1 
18:2 
18:3 
0. 99 
1. 01 
2. 61 
6. 07 
0. 27 
2. 14 
4. 15 
0. 70 
0. 08 
0. 00 
0. 00 
0. 10 
2. 46 
0. 00 
1. 55 
11. 78 
2, 77 
0. 10 
0. 00 
0. 00 
0. 00 
1. 48 
0. 00 
0. 92 
3. 29 
12. 24 
0. 08 
0. 00 0. 00 0. 00 
0. 00 0. 00 0. 00 
0. 00 0. 00 0. 00 
7. 00 7, 89 5. 61 
0. 06 0. 04 0. 04 
0. 64 0. 85 0. 87 
8. 58 7. 62 6. 27 
1. 99 7. 62 4. 73 
0. 06 0. 08 0. 08 
* BUT, butter; PAR, Parkay margarine; SUN, sunflower oil; CPO, crude 
palm oil; RPO, refined palm oil; and SPO, sunflower/palm oil blend. 
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TABLE 6 
Amounts of fatty acids per serving of modified molasses cookie* 
BUT PAR SUN CPO RPO SPO 
total fatty 
acids 
10:0 
12:0 
14:0 
16:0 
16:1 
18:0 
18:1 
18:2 
18:3 
2. 26 
0. 11 
0, 12 
0. 30 
0. 71 
0. 03 
0. 25 
0. 48 
0. 08 
0. 01 
2. 25 
0. 00 
0. 00 
0. 01 
0. 28 
0. 00 
0. 18 
1. 35 
0. 32 
0. 01 
2. 33 2. 33 2. 33 
0. 00 0. 00 0. 00 
0. 00 0. 00 0. 00 
0, 00 0. 00 0. 00 
0. 18 0. 87 0. 98 
0. 00 0. 01 0. 00 
0. 11 0. 08 0. 18 
0. 41 1. 06 0. 95 
1. 52 0. 25 0. 21 
0. 01 0. 01 0. 01 
2. 35 
0. 00 
0. 00 
0. 00 
0. 69 
0. 00 
0. 11 
0. 78 
0. 59 
0. 01 
* BUT, butter; PAR, Parkay margarine; SUN, sunflower oil; CPO, 
palm oil; RPO, refined palm oil; and SPO, sunflower/palm oil 
crude 
blend. 
TABLE 7 
Amounts of fatty acids per serving of modified sugar cookie* 
BUT PAR SUN CPO RPO SPO 
total fatty 
acids 
10:0 
12:0 
14:0 
16:0 
16:1 
18:0 
18:1 
18:2 
18:3 
2. 22 
0. 11 
0. 12 
0, 30 
0. 67 
0. 03 
0. 24 
0. 47 
0. 08 
0. 01 
2. 21 
0. 00 
0. 00 
0. 01 
0. 28 
0. 00 
0. 17 
1. 32 
0. 31 
0. 01 
2. 27 2. 27 2. 27 
0. 00 0. 00 0. 00 
0. 00 0. 00 0. 00 
0. 00 0. 00 0. 00 
0, 18 0. 85 0. 95 
0. 00 0. 01 0. 00 
0. 11 0. 08 0. 10 
0. 40 1. 04 0. 92 
1. 48 0. 24 0. 20 
0. 01 0. 01 0. 01 
2. 29 
0. 00 
0. 00 
0. 00 
0. 68 
0, 00 
0. 11 
0. 76 
0. 57 
0. 01 
* BUT, butter; PAR, Parkay margarine; SUN, sunflower oil; CPO, 
palm oil; RPO, refined palm oil; and SPO, sunflower/palm oil 
crude 
blend, 
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TABLE 8 
Dietary intake of kcals as fat and kcals as modified fat* 
BUT PAR SUN CPO RPO SPO Goal 
Kcals as 
fat 
36. 71 39. 03 35. 72 38. 68 34. 86 42. 06 40. 00 
Kcals as 
modified fat 
21. 85 14. 04 18. 44 19. 14 15. 92 16. 47 24. 00 
* BUT, butter; PAR, Parkay margarine; SUN, sunflower oil; CPO, cru e 
palm oil; RPO, refined palm oil; and SPO, sunflower/palm oil blend. 
TABLE 9 
Dietary intake of modified fat of total fat* 
Dietary Group 
Average Intake 
Modified Fat 
of Total Fat Goal 
BUT 
PAR 
SUN 
CPO 
RPO 
SPO 
61. 85 
35. 81 
50. 68 
45. 02 
45. 41 
39. 01 
60. 00 
60. 00 
60. 00 
60. 00 
60. 00 
60. 00 
* BUT, butter; PAR, Parkay margarine; SUN, sunflower oil; CPO, crude 
palm oil; RPO, refined palm oil; and SPO, sunflower/palm oil blend. 
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TABLE 10 
Dietary intake of magnesium, calcium, and potassiumw 
RDA Reference 
BUT PAR SUN CPO RPO SPO or Mean Value 
EMR 
Magnesium 
lo RDA 
Calcium 
f RDA 
Potassium 
% EMR 
mg 
317 309 254 261 327 259 350 289 
83 
906 1007 887 1160 1312 1201 800 1078 
135 
3318 3422 2949 3287 3613 2918 2000 3251 
163 
298 
85 
868 
109 
2930 
147 
* BUT, butter; PAR, Parkay margarine; SUN, sunflower oil; CPO, crude 
palm oil; RPO, refined palm oil; SPO, sunflower/palm oil blend; RDA, 
Recommended Dietary Allowance; and EMR, Estimated Minimum 
Requirement. 
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treatment group and are listed in Table 11. 
CLINICAL DATA 
Anthropometric Data 
Anthropometric data collected before the beginning of the 
study, including height, weight, age, and body mass index (BMI), is 
listed in Table 12. Body mass index is weight (kilograms) divided by 
height (meters squared). 
Individual variations in weight throughout Diet Period 4 ranged 
from -4. 32 to +2. 5 kilograms from week 0 to week 6. Only two of the 
subjects' weights varied more than five pounds (2. 27 kilograms) from 
their original weight at week 0. Table 13 provides the average 
weight variations by dietary group. None of these variations in 
weight among treatment groups were significantly different. 
Diastolic Blood Pressure 
Table 14 lists the mean diastolic blood pressures (DBPs) by 
week within treatment. DBPs during week 0, week 3, and week 6 were 
not significantly different. Treatment had no significant effect on 
DBP. Week also had no significant effect on DBP, and there was no 
significant week by treatment interaction. 
DBP was highly correlated (p &0, 001) with systolic blood 
pressure (SBP), but not with any other variable. Correlation 
coefficients between DBP and other variables can be found in Table 
15. 
Systolic Blood Pressure 
Mean systolic blood pressures (SBPs) during week 0 were 
significantly different (p &0. 05, r=0. 60), but they were not 
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TABLE 11 
Dietary intakes of linoleic acid and P:S ratios" 
Reference 
BUT PAR SUN CPO RPO SPO Value 
Linoleic Acid 
(% kcals) 2. 48 5. 24 14, 45 3. 87 3. 46 10. 32 5, 07 
P:S Ratio 0. 13 0, 55 1. 39 0. 27 0. 27 0. 98 
* BUT, butter; PAR, Parkay margarine; SUN, sunflower oi ; CPO, crude 
palm oil; RPO, refined palm oil; SPO, sunflower/palm oil blend; 
and P:S ratio, polyunsaturated to saturated fatty acid ratio. 
TABLE 12 
Weight (kg), height (cm), age, and body mass index (BMI) of subjects 
by treatment group* 
(Mean + standard deviation) 
Treatment Weight Height Age BMI 
BUT 
PAR 
SUN 
CPO 
RPO 
SPO 
kg 
92. 07 4. 27 
76. 25 3. 67 
78. 90 2. 27 
84. 85 3. 81 
82. 22 4. 69 
85. 00 3. 72 
cm 
180. 17 2. 07 
172. 88 2. 98 
177. 75 2. 28 
179. 88 3. 37 
180. 63 4, 08 
181. 17 1. 91 
years 
37. 33 0. 85 28. 35 1. 13 
38. 25 3. 44 25. 26 0. 66 
42. 00 3. 46 24. 97 0. 57 
46. 50 3. 65 26. 12 0. 40 
37. 50 1. 15 25. 13 0. 65 
42. 00 6. 55 25. 98 1. 63 
BUT, butter; PAR, Par ay margarine; SUN, sunflower oil; CPO, cru e 
palm oil; RPO, refined palm oil; SPO, sunflower/palm oil blend; 
Kg, kilogram; Cm, centimeter; and BNI, body mass index. 
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TABLE 13 
Average variation in weight (kg) from week 0 to week 6 by dietary 
group* 
Dietary Group Weight Variation 
BUT 
PAR 
SUN 
CPO 
RPO 
SPO 
kg 
0. 80 
0. 64 
0, 59 
0. 62 
0. 28 
1. 74 
* BUT, butter; PAR, Par ay margarine; SUN, sunflower oil; CPO, crude 
palm oil; RPO, refined palm oil; SPO, sunflower/palm oil blend; 
and kg, kilogram. 
TABLE 14 
Mean diastolic blood pressures by week within treatment* 
(Mean w SEN) 
Week 
BUT 
PAR 
SUN 
CPO 
RPO 
SPO 
67, 0 + 3. 46 
77, 0 + 3. 99 
65. 4 + 3. 09 
79. 0 + 3. 46 
68. 0 + 6. 91 
69. 0 + 3. 99 
mm Hg 
69. 5 + 3. 94 
75. 3 + 4. 55 
66. 0 + 3. 53 
75. 0 + 3, 94 
74. 0 + 7. 88 
71. 3 i 4. 55 
69. 5 + 3. 65 
78. 7 + 4. 21 
67. 6 + 3. 26 
76. 0 + 3. 65 
71. 0 + 7. 30 
67. 7 + 4. 21 
* BUT, butter; PAR, Parkay margarine; SUN, sunflower oi ; CPO, crude 
palm oil; RPO, refined palm oil; and SPO, sunflower/palm oil blend. 
41 
TABLE 15 
Correlation matrix between variables* 
Mg Ca K SBP DBP MgI CaI KI 
Mg 
Ca 
SBP 
DBP 
MgI 
CaI 
KI 
1. 00 0. 32 0. 13 0. 07 0. 09 0. 21 0. 26 0. 29 
0. 32 1. 00 0. 33 0. 31 0. 31 0. 33 0. 37 0, 47+ 
0. 13 0. 33 1. 00 0. 26 0. 19 0, 15 0. 32 0. 20 
0 07 0 31 0. 26 1 00 0. 601 0 31 0 23 0 18 
0. 09 0 31 0. 19 0. 601 1 00 0 31 0 32 0 30 
0. 21 0. 33 0. 15 0. 31 0. 31 1. 00 0. 43+ 0. 85$ 
0. 26 0. 37 0. 32 0. 23 0. 32 0. 43+ 1. 00 0. 588 
0. 29 0. 47+ 0. 20 0. 18 0. 30 0. 85$ 0. 586 1. 00 
* Mg, erythrocyte magnesium concentration; Ca, erythrocyte ca cium 
concentration; K, erythrocyte potassium concentration; SBP, 
systolic blood pressure; DBP, diastolic blood pressure; MgI, 
magnesium intake; CaI, calcium intake; and KI, potassium intake. 
+ Significant, p &0. 05. 
) Significant, p &0. 0001. 
8 Significant, p &0. 005. 
) Significant, p &0. 001. 
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significantly different during week 3 and week 6. Treatment had an 
effect on SBP (p &0. 05) but there was no week effect or week by 
treatment interaction. Table 16 lists the mean SBPs by treatment 
group, 
SBP was significantly correlated (p &0. 001) with diastolic 
blood pressure, but not with any other variable. Table 15 lists 
correlation coefficients between SBP and other variables. 
Erythrocyte Mineral Concentrations 
Table 17 lists the mean magnesium concentration of red blood 
cells by week within treatment group. There were no significant 
differences found in magnesium concentration during week 0 or week 6. 
However, there were significant differences among magnesium 
concentrations during week 3 (p &0. 05). Neither treatment nor week 
had a significant effect on magnesium concentration, There was no 
significant week by treatment interaction. 
Table 15 provides the correlation coefficients of magnesium 
concentration with other variables. Magnesium concentration was not 
significantly correlated with any other variable, 
Red blood cell calcium concentration was not significantly 
different during week 0, week 3, or week 6. Table 18 lists the mean 
calcium concentration of red blood cells by week within treatment 
group. 
Treatment did not have a significant effect on calcium 
concentration. Week, however, did have a significant effect on 
calcium concentration in red blood cells (p &0. 05), but there was no 
significant week by treatment interaction. 
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TABLE 16 
Mean systolic blood pressures (SBP) by week within treatment* 
(Mean + SEM) 
Meek 
BUT 
PAR 
SUN 
CPO 
RPO 
SPO 
106. 0 + 2. 52 
118. 3 + 2. 91 
110. 4 + 2. 25 
112. 8 + 2. 52 
123. 0 + 5. 03 
107. 8 + 2. 91 
mm Hg 
113. 0 + 3. 39 
119. 0 + 3. 91 
111. 4 + 3. 03 
120. 0 + 3. 39 
120. 0 + 6. 77 
113. 7 + 3. 91 
111. 5 + 4. 25 
120. 0 + 4. 91 
104. 2 + 3. 80 
117. 0 + 4, 25 
124. 0 + 8. 50 
112. 0 0 4. 91 
* BUT, butter; PAR, Parkay margarine; SUN, sunflower oil; CPO, crude 
palm oil; RPO, refined palm oil; and SPO, sunflower/palm oil blend. 
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TABLE 17 
Mean erythrocyte magnesium concentration by week within treatment* 
(Mean + SEM) 
Week 
BUT 
PAR 
SUN 
CPO 
RPO 
SPO 
638. 44 + 224. 43 
657. 45 + 173. 84 
716. 15 + 173. 84 
822. 84 t 173. 84 
854. 20 + 224. 43 
365. 77 + 224. 43 
PPM 
898. 47 + 99. 64 
567. 45 + 77. 18 
768, 28 + 77. 18 
880. 98 + 77. 18 
610. 24 + 99. 64 
555. 60 + 99. 64 
996. 47 + 133. 88 
894. 97 + 103. 70 
768. 46 + 103. 70 
802. 13 + 103. 70 
844. 60 + 133, 88 
867. 73 + 133. 88 
* BUT, butter; PAR, Parkay margarine; SUN, sunflower oil; CPO, crude 
palm oil; RPO, refined palm oil; SPO, sunflower/palm oil blend; 
and PPM, parts per million. 
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TABLE 18 
Mean erythrocyte calcium concentration by week within treatment* 
(Mean t SEM) 
Meek 
BUT 
PAR 
SUN 
CPO 
RPO 
SPO 
12. 05 t 0. 80 
12. 07 + 0. 62 
13. 11 + 0. 62 
14. 72 + 0. 62 
13. 88 + 0. 80 
13. 76 + 0. 80 
PPM 
14. 46 + 1. 68 
13. 49 + 1. 30 
16. 24 + 1. 30 
13. 39 + 1. 30 
12. 99 + 1. 68 
13. 81 + 1. 68 
13. 21 + 1. 07 
12. 33 + 0. 83 
10. 48 + 0. 83 
12. 59 + 0, 83 
12. 03 + 1. 07 
12. 32 + 1. 07 
* BUT, butter; PAR, Parkay margarine; SUN, sunflower oil; CPO, crude 
palm oil; RPO, refined palm oil; SPO, sunflower/palm oil blend; 
and PPM, parts per million. 
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Calcium concentration was significantly correlated with 
potassium intake (p& 0. 05), but not with any other variable. Table 
15 lists the correlation coefficients of calcium concentration with 
other variables. 
There were no significant differences among potassium 
concentrations during week 0, week 3, or week 6. Table 19 lists the 
mean potassium concentration of red blood cells by week within 
treatment group. 
Treatment had no significant effect on potassium concentration, 
Week, however, had a significant effect on potassium concentration (p 
&0. 01), but there was no significant week by treatment interaction. 
Red blood cell potassium concentration was not correlated with 
other variables. Table 15 lists the correlation coefficients of 
potassium concentration with other variables. 
Correlations with Dietary Intake of Minerals 
Magnesium intake was significantly correlated with infake of 
calcium (p &0. 05) and potassium (p &0. 0001). Similarly, dietary 
calcium was found to be significantly correlated with potassium 
intake (p &0. 005) and magnesium (p &0. 05). Correlation coefficients 
are listed in Table 15. There were no significant correlations among 
dietary minerals and erythrocyte mineral concentrations (Table 15). 
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TABLE 19 
Mean erythrocyte potassium concentration by week within treatment» 
(Mean + SEM) 
Meek 
BUT 
PAR 
SUN 
CPO 
RPO 
SPO 
2626. 04 + 316. 26 
2565. 65 + 244. 97 
2804. 94 + 244. 97 
2576. 88 + 244. 97 
2994. 24 + 316. 26 
2622. 55 + 316. 26 
PPM 
2298. 94 + 275. 53 
2148. 86 + 213. 42 
2492, 56 + 213. 42 
1960. 87 + 213. 42 
1830. 50 + 275. 53 
1754. 98 + 275. 53 
2996. 29 + 353. 24 
1845. 44 + 273. 62 
2308. 43 + 273. 62 
2460. 33 + 273. 62 
2363. 70 + 353. 24 
1902. 16 + 353. 24 
* BUT, butter; PAR, Parkay margarine; SUN, sunflower oil; CPO, crude 
palm oil; RPO, refined palm oil; SPO, sunflower/palm oil blend; 
and PPN, parts per million. 
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DISCUSSION 
Six different types of test fats were incorporated into the 
diets of 29 men. The subjects' blood pressures and red blood cell 
magnesium, calcium, and potassium were measured at intervals 
throughout one of six diet periods, although the original plan of 
this study was to analyze blood pressures and red blood cell minerals 
from two or three diet periods. 
An average of seven days of food intake records was used to 
compute the dietary data in this study. Several days of food intake 
records have been shown to be more accurate than 24-hour recalls in 
determining usual and current intake of nutrients (144). 
Subjects were asked to keep three days of food intake records 
at three different times throughout diet period four, during week 0, 
week 3, and week 6, rather than for nine consecutive days. Record 
keeping for longer than seven consecutive days may become tedious and 
result in greater error (144). 
The majority of the subjects in this study consumed less than 
recommended (goal) levels of calories from fat and calories from 
modified fat (Tables 8-9). This may have been due in part to the 
less than favorable response to the taste, smell, and appearance of 
some of the modified foods, and to the difficulty that some of the 
subjects had modifying their usual intake of fat, particularly if the 
subjects typically ate a diet low in fat relative to the study's 
goals. 
Average fat intake among study participants was similar to 
reference values found in the literature ( 145). Although fat intake 
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was higher than the level which is recommended for Americans by the 
American Heart Association, National Research Council, and National 
Cholesterol Education Program (146), fat intake was comparable to 
typical fat intake among Americans, particularly among American men 
aged 19-50 years (147). 
Linoleic acid intake, expressed as percentage of calories, 
varied according to treatment group and test fat (Table 11). 
Linoleic acid intake for subjects in the Parkay group, however, was 
similar to values found in the literature (145). 
The crude palm oil products were the least acceptable, and 
several of the subjects from the crude palm oil treatment group 
complained of a "motor oil"-like taste and smell, particularly when 
cooking with the products. Ironically, the average percentage of 
calories from modified fat within the crude palm oil treatment group 
was the second highest among all treatment groups, contrary to what 
the author had expected (Table 8). The average percentage of 
calories from modified fat within the butter group, on the other 
hand, was the highest among all treatment groups, as the products 
were generally well accepted (Table 8). 
The average intakes of calcium and potassium in all treatment 
groups met and exceeded the Recommended Dietary Allowance (RDA) of 
800 mg of calcium and the Estimated Minimum Requirement of 2000 mg of 
potassium. The average intake of magnesium, however, did not meet 
the RDA of 350 mg in any of the treatment groups (142). Although the 
average intake of magnesium did not meet the RDA, the average intake 
of magnesium, expressed as a percentage of RDA, did compare favorably 
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to the values found in the literature (Table 10) (143). 
Average calcium intake among study participants was higher than 
reference values found in the literature (Table 10) (145). High 
levels of dietary calcium among study participants may have been 
attributed to the fact that the participants were encouraged to drink 
milk and eat ice cream provided in the study in order to meet the 
study's goals for intake of test fats. 
Average potassium intake among study participants was similar 
to values found in the literature (145), although slightly higher 
than reference values (Table 10). Differences in intake may have been 
due to factors such as geographic or regional differences in 
availability of food and food preferences, seasonal differences, and 
socioeconomic status. 
At the beginning of this study, one of the hypotheses had been 
that blood pressure would decrease in subjects following diets high 
in polyunsaturated fatty acids (linoleic acid). No evidence was 
presented from this study to support this hypothesis. 
There has been evidence presented in the literature which 
indicates that tissue prostaglandin synthesis can be altered by 
increasing the amount of linoleic acid in the diet. Because linoleic 
acid acts as a precursor for prostaglandin synthesis, an increase in 
linoleic acid would essentially increase the substrate concentration 
for prostaglandin synthesis. 
Polyunsaturated fats and oils have also been shown to increase 
the permeability of the RBC membrane to ions. An increase in the 
degree of unsaturation makes a membrane more permeable, and this may 
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affect efflux of electrolytes from red blood cells. However, in this 
study, there was no evidence of this as there were no significant 
changes in RBC minerals. Previous studies have shown an increased 
efflux of electrolytes, including potassium, from erythrocytes in 
subjects after following an oleic acid-enriched diet for three weeks. 
In one study, the oleic acid content of erythrocyte membranes was 
increased while the saturated fatty acid composition was decreased. 
This decrease in the saturated fatty acid composition was associated 
with an increase in potassium efflux ( 130). Hunt and colleagues 
noted that one way that membrane composition may be affected by serum 
lipids is by changing the pore size of the membrane, thereby 
affecting the passive leak of ions (133). 
Both systolic and diastolic blood pressures among study 
participants were lower than reference values found in the literture 
for adult men (148). This may be attributed to the fact that only 
normotensive men were involved in this study. In other words, the 
values found in the literature would reflect blood pressures from a 
representative sample of the total population, not just from 
normotensives. Had hypertensive subjects been included in this 
study, it is possible that greater differences in blood pressure 
would have been seen as a result of treatment. However, other 
studies have shown decreases in blood pressure even among 
normotensive subjects in response to certain dietary factors 
(20, 94, 95). 
Significant changes in blood pressure in response to dietary 
linoleic acid supplementation have been seen in human studies of 
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relatively short duration (19, 20). Comberg and colleagues 
demonstrated a 10 mmHg decrease in diastolic blood pressure in 
hypertensive men after just three weeks of supplementation with 
linoleic acid (19). Similarly, Heagery and coworkers showed a 
decrease in blood pressure in normotensive men after four weeks of 
supplementing the diet with 3 grams of safflower seed oil capsules 
(20). Therefore, it can be concluded that a diet period of six weeks 
duration should have been of sufficient length to detect changes in 
blood pressure in response to dietary fats. 
There is conflict in the literature about which component of 
blood pressure is the more reliable predictor of risk of CHD. 
Researchers have shown that both pressures were statistically 
significant indices of risk of CHD, and an elevation of either 
pressure is a good predictor of the risk of CHD (37-38). Therefore, 
statistical tests were performed on both the systolic and diastolic 
blood pressures, which only acted to increase the blood pressure data 
pool. 
Cellular mineral levels in this study were measured using 
atomic absorption spectrophotometry, a method used to determine 
mineral levels in biological materials. In this study, the 
biological materials (red blood cells) were first ashed, and after 
simple dilution, were aspirated into a flame. The light absorbed at 
a particular wavelength, corresponding to the mineral being measure, 
is compared with the absorption of a standard mineral solution. The 
absorptions of light at the specific wavelengths are proportional to 
the concentrations of minerals in the sample. 
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The red blood cell calcium concentrations calculated in this 
study compared quite favorably to concentrations in other studies 
involving erythrocyte calcium. Calcium concentrations in this study 
ranged from 10. 48 to 16. 24 PPM (0. 524 to 0. 736 mEq/1). Normal levels 
found in the literature ranged from 12. 0 to 28. 0 PPM (0. 6-1. 4 mEq/l) 
(149). 
Potassium levels in this study were significantly lower than 
values found in the literature, probably due to overdilution of the 
samples prior to analysis on the spectrophotometer. The atomic 
absorption reading did not fall within the working range and 
therefore cannot be compared to values in the literature. Potassium 
concentration in this study ranged from 1754. 98 to 2996. 29 PPM 
( 175. 49 to 299. 63 mg/100 ml), Concentrations found in the literature 
range from 3710 to 6050 PPM (371 to 605 mg/100 ml) (149). 
Magnesium concentrations ranged from 365. 77 to 996. 47 PPM 
(36. 58 to 99. 65 mg/100 ml) in this study, a much wider range than 
that found in the literature. Ranges in the literature from studies 
involving direct measurement of erythrocyte magnesium are from 454. 0 
to 655. 0 PPM (45. 4 to 65. 5 mg/100 ml) and 400 to 612 PPM (40. 0-61. 2 
mg/100 ml) (150), Values involving indirect measurement ranged from 
44. 0 to 80 PPM (4. 4 to 8. 0 mg/100 ml) (150). Other erythrocyte 
magnesium concentrations found in the literature include 26 to 131 
PPM (2. 6 to 13. 1 mg/100 ml) and 34 to 56 PPM (3. 4 to 5. 6 mg/100 ml) 
(149), and 45. 71 to 63. 0 PPM (4. 57 to 6. 30 mg/100 ml) (151). 
The results of this study suggest no relationship between blood 
pressures and red blood cell mineral concentrations. At the 
54 
beginning of the study, one hypothesis was that there would be such a 
relationship. Specifically, a positive correlation was expected to 
be found between blood pressure and red blood cell calcium. The fact 
that no evidence to support this hypothesis was observed is contrary 
to evidence presented in other studies which indicated that 
intracellular calcium initiates smooth muscle contraction, and a high 
intracellular calcium enhances the contractile response to 
vasoconstrictive stimuli in systemic HTN (89), An impaired 
intracellular calcium content has been confirmed in patients 
suffering from essential HTN (86). This finding however, does agree 
with the results of Cooper and colieagues, who reported that 
intracellular calcium was not correlated with blood pressure in 
either hypertensives or normotensive subjects (152). Once again, it 
must be noted that all subjects in this study were normotensive, 
which may account for the results. 
An inverse relationship between blood pressure and red blood 
cell magnesium and potassium also was expected. However, results 
from this study did not indicate such a relationship. This is 
contrary to evidence presented in the literature in which magnesium 
deficiency aggravated high blood pressure in spontaneously 
hypertensive rats (51), or with evidence that even small reductions 
in erythrocyte magnesium led to increased blood pressure (153). This 
does agree with evidence, however, that plasma and erythrocyte 
magnesium did not differ significantly between normal pregnant and 
pregnancy-induced hypertensives (75). In addition, this does not 
agree with the concept that a decrease in intracellular potassium 
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causes the cell to be more easily excited and may play a role in the 
development of HTN. 
No significant changes in red blood cell magnesium or calcium 
concentration were found in this clinical trial as a result of a diet 
high in any particular test fat. This is contrary to evidence 
presented in the literature which indicates that dietary linoleic 
acid supplementation may effect the flux of ions across the cell 
membrane (131). This is consistent with results from previous 
studies which indicate that dietary linoleic and oleic acids are 
unlikely to have major effects on membrane-dependent functions of red 
blood cells (135). 
Although the lifespan of the red blood cell is approximately 
120 days, the diet period of this clinical trial was of six weeks 
duration. It is probable that greater differences among erythrocyte 
mineral concentrations may have been seen as a result of treatment if 
the length of the treatment period had corresponded more closely to 
the lifespan of the red blood cell. Heagerty and colleagues, 
however, reported that after just four weeks of supplementing the 
diet with linoleic acid, significant changes were seen in sodium 
transport across the plasma membrane (20). Other studies also have 
shown significant changes in the fatty acid composition and function 
of the red blood cell membrane after just a few weeks (130). 
In this study, dietary calcium was not correlated with blood 
pressure. This disagrees with results from other studies which 
showed a change in either diastolic blood pressure alone (95), a 
decrease in systolic blood pressure with calcium supplementation (90- 
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92), or in both systolic and diastolic blood pressures (93-95. ) Even 
normotensive men showed decreases in systolic and diastolic blood 
pressures in response to calcium supplementation (93, 94). 
There was no evidence presented in this study of a relationship 
between dietary minerals and red blood cell mineral concentrations. 
Moser and colleagues reported similar findings that dietary magnesium 
was not significantly correlated with the level of magnesium in 
either the plasma or erythrocytes (154), 
A significant positive correlation was found among all red 
blood cell mineral levels. Magnesium was positively correlated with 
both calcium and potassium. Calcium was positively correlated with 
magnesium and potassium, and potassium with magnesium and calcium. 
The fact that magnesium and calcium were positively correlated is 
contrary to evidence which indicates that low levels of intracellular 
magnesium may cause an increase in cytosolic calcium (86). The 
subjects in the present study, however, were not magnesium deficient, 
and therefore probably did not have abnormally elevated intracellular 
calcium levels as a result. 
The positive correlation between intracellular concentrations 
of magnesium and potassium found in this study have been similarly 
demonstrated in previous studies (76, 78). Magnesium deficiency has 
also been related to decreased concentrations of potassium in 
lymphocytes (77). 
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CONCLUSION 
This study demonstrates that neither systolic nor di atolic 
blood pressure changed significantly in subjects who followed diets 
rich in crude or refined palm oil, butter or Parkay margarine, 
sunflower oil, or a sunflower/palm oil blend. 
This particular study found no evidence of a relationship 
between blood pressures and red blood cell mineral concentrations. A 
positive correlation was expected to be found between intracellular 
calcium concentrations and blood pressure, and an inverse 
relationship was hypothesized between intracellular magnesium and 
potassium. However, all subjects in this study were normotensive, 
therefore it is difficult to conclude from this study alone that 
there is no relationship between blood pressure and erythrocyte 
minerals. 
This study did not find any change in blood cell mineral 
concentrations in subjects after following a diet rich in any 
particular test fat. 
Red blood cell calcium concentration was found to be correlated 
with both dietary calcium and potassium. No other correlations were 
found between mineral intake and mineral concentration in red blood 
cells. 
All three erythrocyte minerals were found to be positively 
correlated with each other. The relationship between magnesium and 
potassium concentrations is supported by findings from previous 
studies, but the relationship between intracellular magnesium and 
calcium contradicts previous research. 
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APPENDIX 
1% Lanthanum Chloride Solution: 
Formula Weight LaC1~. 7H20 = 371. 38 
15. 142 grams LaC13/1000 ml H20 
5% EDTA Solution: 
Formula Weight Na2CIDHI400N2. 2H20 = 372. 24 
52. 54 grams/1000 ml 
10% Nitric Acid Solution: 
100 ml nitric acid/1000 ml distilled deionized H20 
(50 ml/weight of sample 1) X spectrophotometer reading X Dilution 
Factor = PPM 1 
(50 ml/weight of sample 2) X spectrophotometer reading X Dilution 
Factor = PPM 2 
(PPM 1 + PPM 2) / 2 = Average PPM 
Dilution Factors: 
Magnesium 
Potassium 
Calcium 
500 
397 
1 
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